← Eichor
Study identifier: NCT06828393 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Phase 1 Study of S-1117

Condition: Healthy Volunteer  ·  Sponsor: Seismic Therapeutic AU Pty Ltd

PhasePhase 1
Planned participants96
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersYes

About this study

This is the first-in-human study of S-1117 designed to provide safety, tolerability, pharmacokinetic, and pharmacodynamic data in healthy volunteers.

This description comes directly from the study's public registry record.

Talk to the study team

Seismic Contact  ·  1800 244 475  ·  clinical@seismictx.com

Always discuss trial participation with your own doctor first.

Locations (1)

CMAX Clinical ResearchAdelaide, South Australia, AustraliaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06828393